Literature DB >> 11278860

Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.

B M Loo1, J Kreuger, M Jalkanen, U Lindahl, M Salmivirta.   

Abstract

Fibroblast growth factors (FGFs) are heparin-binding polypeptides that affect the growth, differentiation, and migration of many cell types. FGFs signal by binding and activating cell surface FGF receptors (FGFRs) with intracellular tyrosine kinase domains. The signaling involves ligand-induced receptor dimerization and autophosphorylation, followed by downstream transfer of the signal. The sulfated glycosaminoglycans heparin and heparan sulfate bind both FGFs and FGFRs and enhance FGF signaling by mediating complex formation between the growth factor and receptor components. Whereas the heparin/heparan sulfate structures involved in FGF binding have been studied in some detail, little information has been available on saccharide structures mediating binding to FGFRs. We have performed structural characterization of heparin/heparan sulfate oligosaccharides with affinity toward FGFR4. The binding of heparin oligosaccharides to FGFR4 increased with increasing fragment length, the minimal binding domains being contained within eight monosaccharide units. The FGFR4-binding saccharide domains contained both 2-O-sulfated iduronic acid and 6-O-sulfated N-sulfoglucosamine residues, as shown by experiments with selectively desulfated heparin, compositional disaccharide analysis, and a novel exoenzyme-based sequence analysis of heparan sulfate oligosaccharides. Structurally distinct heparan sulfate octasaccharides differed in binding to FGFR4. Sequence analysis suggested that the affinity of the interaction depended on the number of 6-O-sulfate groups but not on their precise location.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278860     DOI: 10.1074/jbc.M011226200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.

Authors:  Tobias Miller; Melissa C Goude; Todd C McDevitt; Johnna S Temenoff
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

2.  Molecular mechanisms of heparin-induced modulation of human interleukin 12 bioactivity.

Authors:  Khue G Nguyen; Francis B Gillam; Jared J Hopkins; Srinivas Jayanthi; Ravi Kumar Gundampati; Guowei Su; Jenifer Bear; Guy R Pilkington; Rashmi Jalah; Barbara K Felber; Jian Liu; Suresh Kumar Thallapuranam; David A Zaharoff
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

3.  Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains.

Authors:  Gregory O Staples; Xiaofeng Shi; Joseph Zaia
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

4.  Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complex.

Authors:  Krishna Saxena; Ulrich Schieborr; Oliver Anderka; Elke Duchardt-Ferner; Bettina Elshorst; Santosh Lakshmi Gande; Julia Janzon; Denis Kudlinzki; Sridhar Sreeramulu; Matthias K Dreyer; K Ulrich Wendt; Corentin Herbert; Philippe Duchaussoy; Marc Bianciotto; Pierre-Alexandre Driguez; Gilbert Lassalle; Pierre Savi; Moosa Mohammadi; Françoise Bono; Harald Schwalbe
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

5.  FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease.

Authors:  Susana Garcia-Recio; Aatish Thennavan; Michael P East; Joel S Parker; Juan M Cejalvo; Joseph P Garay; Daniel P Hollern; Xiaping He; Kevin R Mott; Patricia Galván; Cheng Fan; Sara R Selitsky; Alisha R Coffey; David Marron; Fara Brasó-Maristany; Octavio Burgués; Joan Albanell; Federico Rojo; Ana Lluch; Eduardo Martinez de Dueñas; Jeffery M Rosen; Gary L Johnson; Lisa A Carey; Aleix Prat; Charles M Perou
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

6.  Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function.

Authors:  Johan Kreuger; Taro Matsumoto; Maarten Vanwildemeersch; Takako Sasaki; Rupert Timpl; Lena Claesson-Welsh; Dorothe Spillmann; Ulf Lindahl
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

Review 7.  Biology of FGFRL1, the fifth fibroblast growth factor receptor.

Authors:  Beat Trueb
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

8.  Selective activation of TACI by syndecan-2.

Authors:  Daniela Bischof; Sherine F Elsawa; George Mantchev; Juhan Yoon; Grace E Michels; Allan Nilson; Shari L Sutor; Jeffrey L Platt; Stephen M Ansell; Gotz von Bulow; Richard J Bram
Journal:  Blood       Date:  2005-12-15       Impact factor: 22.113

9.  Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells.

Authors:  Sabrina Cattaruzza; Ugur Ozerdem; Martin Denzel; Barbara Ranscht; Pietro Bulian; Ugo Cavallaro; Daniela Zanocco; Alfonso Colombatti; William B Stallcup; Roberto Perris
Journal:  Angiogenesis       Date:  2012-11-04       Impact factor: 9.596

10.  Heparin accelerates gelsolin amyloidogenesis.

Authors:  Ji Young Suk; Fuming Zhang; William E Balch; Robert J Linhardt; Jeffery W Kelly
Journal:  Biochemistry       Date:  2006-02-21       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.